Boccuzi Joseph H 4
4 · Allergan plc · Filed May 12, 2020
Insider Transaction Report
Form 4
Allergan plcAGN
Boccuzi Joseph H
Director
Transactions
- Disposition to Issuer
Ordinary Shares, par value $0.0001
2020-05-08−3,605→ 0 total
Footnotes (1)
- [F1]Reflects the disposition of ordinary shares ("Allergan Shares") of Allergan plc ("Allergan") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. ("AbbVie"), Venice Subsidiary, LLC ("Acquirer Sub") and Allergan (the "Transaction Agreement"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the "Scheme"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share.